BRISTOL-MYERS SQUIBB PHARMA EEIG
- B03 - Preparados antianémicos
- REBLOZYL powder and solvent for solution for injection 25 mg
- REBLOZYL powder and solvent for solution for injection 75 mg
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- BARACLUDE oral solution 0.05 mg/ml
- EVOTAZ film-coated tablet 300 mg+150 mg
- REYATAZ capsule, hard 100 mg
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- REYATAZ capsule, hard 300 mg
- REYATAZ oral powder 50 mg
- REYATAZ oral powder 50 mg/1.5 g
- L01 - Antineoplásicos
- ABRAXANE lyophilisate for solution for infusion 100 mg
- ABRAXANE lyophilisate for solution for infusion 250 mg
- EMPLICITI powder for solution for infusion 300 mg
- EMPLICITI powder for solution for infusion 400 mg
- ONUREG film-coated tablet 200 mg
- ONUREG film-coated tablet 300 mg
- OPDIVO concentrate for solution for infusion 10 mg/ml
- VIDAZA powder for suspension for injection 25 mg/ml
- YERVOY concentrate for solution for infusion 200 mg/40 ml
- YERVOY concentrate for solution for infusion 50 mg/10 ml
- L04 - Inmunosupresores
- NULOJIX powder for solution for infusion 250 mg
- ORENCIA powder for solution for infusion 250 mg
- ORENCIA PREFILLED SYRINGE solution for injection 125 mg/1 ml
- ORENCIA PREFILLED SYRINGE solution for injection 50 mg/0.4 ml
- ORENCIA PREFILLED SYRINGE solution for injection 87.5 mg/0.7 ml
- REVLIMID capsule, hard 10 mg
- REVLIMID capsule, hard 15 mg
- REVLIMID capsule, hard 2.5 mg
- REVLIMID capsule, hard 20 mg
- REVLIMID capsule, hard 25 mg
- REVLIMID capsule, hard 5 mg
- REVLIMID capsule, hard 7.5 mg
- THALIDOMIDE BMS capsule, hard 50 mg
- ZEPOSIA capsule, hard 0.23 mg - 0.46 mg
- ZEPOSIA capsule, hard 0.92 mg